Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

Clinical trial NCT00106600 · COMPLETED

Trial details

NCT number: NCT00106600
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2005-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.